225 related articles for article (PubMed ID: 33054801)
1. LC-MS/MS-based in vitro and in vivo investigation of blood-brain barrier integrity by simultaneous quantitation of mannitol and sucrose.
Noorani B; Chowdhury EA; Alqahtani F; Ahn Y; Patel D; Al-Ahmad A; Mehvar R; Bickel U
Fluids Barriers CNS; 2020 Oct; 17(1):61. PubMed ID: 33054801
[TBL] [Abstract][Full Text] [Related]
2. Simultaneous UPLC-MS/MS analysis of two stable isotope labeled versions of sucrose in mouse plasma and brain samples as markers of blood-brain barrier permeability and brain vascular space.
Chowdhury EA; Alqahtani F; Bhattacharya R; Mehvar R; Bickel U
J Chromatogr B Analyt Technol Biomed Life Sci; 2018 Jan; 1073():19-26. PubMed ID: 29232607
[TBL] [Abstract][Full Text] [Related]
3. Development and validation of a sensitive UPLC-MS/MS method for the quantitation of [(13)C]sucrose in rat plasma, blood, and brain: Its application to the measurement of blood-brain barrier permeability.
Miah MK; Bickel U; Mehvar R
J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Mar; 1015-1016():105-110. PubMed ID: 26919445
[TBL] [Abstract][Full Text] [Related]
4. A Semi-Physiological Three-Compartment Model Describes Brain Uptake Clearance and Efflux of Sucrose and Mannitol after IV Injection in Awake Mice.
Noorani B; Chowdhury EA; Alqahtani F; Sajib MS; Ahn Y; Nozohouri E; Patel D; Mikelis C; Mehvar R; Bickel U
Pharm Res; 2022 Feb; 39(2):251-261. PubMed ID: 35146590
[TBL] [Abstract][Full Text] [Related]
5. Effects of hepatic ischemia-reperfusion injury on the blood-brain barrier permeability to [
Miah MK; Bickel U; Mehvar R
Metab Brain Dis; 2017 Dec; 32(6):1903-1912. PubMed ID: 28779418
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of [
Miah MK; Chowdhury EA; Bickel U; Mehvar R
J Pharm Sci; 2017 Jun; 106(6):1659-1669. PubMed ID: 28238901
[TBL] [Abstract][Full Text] [Related]
7. An improved low-permeability in vitro-model of the blood-brain barrier: transport studies on retinoids, sucrose, haloperidol, caffeine and mannitol.
Franke H; Galla HJ; Beuckmann CT
Brain Res; 1999 Feb; 818(1):65-71. PubMed ID: 9914438
[TBL] [Abstract][Full Text] [Related]
8. Mannitol opening of the blood-brain barrier: regional variation in the permeability of sucrose, but not 86Rb+ or albumin.
Brown RC; Egleton RD; Davis TP
Brain Res; 2004 Jul; 1014(1-2):221-7. PubMed ID: 15213006
[TBL] [Abstract][Full Text] [Related]
9. In vitro models of the blood-brain barrier to polar permeants: comparison of transmonolayer flux measurements and cell uptake kinetics using cultured cerebral capillary endothelial cells.
Johnson MD; Anderson BD
J Pharm Sci; 1999 Jun; 88(6):620-5. PubMed ID: 10350498
[TBL] [Abstract][Full Text] [Related]
10. Development of Human in vitro Brain-blood Barrier Model from Induced Pluripotent Stem Cell-derived Endothelial Cells to Predict the in vivo Permeability of Drugs.
Li Y; Sun X; Liu H; Huang L; Meng G; Ding Y; Su W; Lu J; Gong S; Terstappen GC; Zhang R; Zhang W
Neurosci Bull; 2019 Dec; 35(6):996-1010. PubMed ID: 31079318
[TBL] [Abstract][Full Text] [Related]
11. Enhancement of blood-brain barrier permeability by sodium caprate.
Ohnishi T; Aida K; Awazu S
J Pharm Pharmacol; 1999 Sep; 51(9):1015-8. PubMed ID: 10528983
[TBL] [Abstract][Full Text] [Related]
12. Permeability of proteins at the blood-brain barrier in the normal adult mouse and double transgenic mouse model of Alzheimer's disease.
Poduslo JF; Curran GL; Wengenack TM; Malester B; Duff K
Neurobiol Dis; 2001 Aug; 8(4):555-67. PubMed ID: 11493021
[TBL] [Abstract][Full Text] [Related]
13. Studies of blood-brain barrier permeability of gastrodigenin in vitro and in vivo.
Mi Y; Mao Y; Cheng H; Ke G; Liu M; Fang C; Wang Q
Fitoterapia; 2020 Jan; 140():104447. PubMed ID: 31805306
[TBL] [Abstract][Full Text] [Related]
14. Side by side comparison between dynamic versus static models of blood-brain barrier in vitro: a permeability study.
Santaguida S; Janigro D; Hossain M; Oby E; Rapp E; Cucullo L
Brain Res; 2006 Sep; 1109(1):1-13. PubMed ID: 16857178
[TBL] [Abstract][Full Text] [Related]
15. In vivo and in vitro evidence for nonrestricted transport of 2',7'-bis(2-carboxyethyl)-5(6)-carboxyfluorescein tetraacetoxymethyl ester at the blood-brain barrier.
Hirohashi T; Terasaki T; Shigetoshi M; Sugiyama Y
J Pharmacol Exp Ther; 1997 Feb; 280(2):813-9. PubMed ID: 9023295
[TBL] [Abstract][Full Text] [Related]
16. A Quasi-Physiological Microfluidic Blood-Brain Barrier Model for Brain Permeability Studies.
Noorani B; Bhalerao A; Raut S; Nozohouri E; Bickel U; Cucullo L
Pharmaceutics; 2021 Sep; 13(9):. PubMed ID: 34575550
[TBL] [Abstract][Full Text] [Related]
17. Comparison of in vitro and in vivo models of drug transcytosis through the blood-brain barrier.
Pardridge WM; Triguero D; Yang J; Cancilla PA
J Pharmacol Exp Ther; 1990 May; 253(2):884-91. PubMed ID: 2338660
[TBL] [Abstract][Full Text] [Related]
18. Development of a humanized in vitro blood-brain barrier model to screen for brain penetration of antiepileptic drugs.
Cucullo L; Hossain M; Rapp E; Manders T; Marchi N; Janigro D
Epilepsia; 2007 Mar; 48(3):505-16. PubMed ID: 17326793
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of transforming growth factor beta signaling pathway promotes differentiation of human induced pluripotent stem cell-derived brain microvascular endothelial-like cells.
Yamashita M; Aoki H; Hashita T; Iwao T; Matsunaga T
Fluids Barriers CNS; 2020 May; 17(1):36. PubMed ID: 32456699
[TBL] [Abstract][Full Text] [Related]
20. Overcoming the blood-brain barrier? - prediction of blood-brain permeability of hydrophobically modified polyethylenimine polyplexes for siRNA delivery into the brain with in vitro and in vivo models.
Hartl N; Gabold B; Adams F; Uhl P; Oerter S; Gätzner S; Metzger M; König AC; Hauck SM; Appelt-Menzel A; Mier W; Fricker G; Merkel OM
J Control Release; 2023 Aug; 360():613-629. PubMed ID: 37437848
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
